January 20, 2017
Where do you stand against influenza
Flu, or influenza, is a very contagious, acute, viral respiratory infection. Influenza viruses vary in a high degree. The extent…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
January 20, 2017
Sanofi’s M&A misses frustrate some investors in drugmaker
For the last year, Sanofi’s chief executive has made clear his quest for deals to help revive the fortunes of France’s biggest drugmaker.
The market is still waiting. Olivier Brandicourt’s failure to land two big biotech acquisitions he was chasing has led to growing impatience among some investors.
January 20, 2017
Abzena nets $300 million for its ThioBridge technology
Abzena has made a deal with a San Diego-based biopharmaceutical company for Abzena’s novel site–specific ThioBridge antibody drug conjugate (ADC) linker technology, which links antibodies and other proteins to drugs. The $300 million worth agreement with the…
January 20, 2017
Cerenis satisfied with Q4 2016, expects good news from clinic in Q1 2017
French company Cerenis Therapeutics has seen some good things happen in the previous period in clinics by finalizing certain studies and getting FDA’s approval to kick some off. Also certain results showed progress and the company has reported solid cash position for the end of the year.
January 20, 2017
Japanese MHLW OK’s Bayer’s cancer drug
Japanese Ministry of Health, Labour and Welfare (MHLW) has granted priority review to Bayer Yakuhin for regorafenib in the second-line…
January 19, 2017
NeuroVive presents positive preclinical data in hepatocellular cancer at HCC Summit
NeuroVive Pharmaceutical’s abstract with novel preclinical cancer data related to the company’s sanglifehrin-based compounds has been accepted for presentation at…
January 19, 2017
Summit Therapeutics’s R&D adviser becomes COO, President of Research Development
Summit Therapeutics has named its research and development adviser Dr David Roblin as new Chief Operating Officer (COO) and President of Research Development.
January 19, 2017
PledPharma’s Nomination Committee wants board changes
PledPharma’s Nomination Committee has submitted a proposal for a new composition of the Board of Directors for consideration at an…
January 19, 2017
GSK takes AstraZeneca’s European Executive Vice President to its team
GlaxoSmithKline has appointed Luke Miels President, Global Pharmaceuticals, GSK. He will be responsible for a portfolio of medicines and vaccines with annual sales of more than £15 billion and operations in over 100 markets.
January 19, 2017
Adocia plans private placement, wants to partner up on “more mature projects”
French drugmaker Adocia, encouraged by the outcome of its project BC Lispro, has set its goal on partnering up with companies that have “more mature projects”, such is Eli Lilly with whom Adocia worked on BC Lispro.